Journal:
:hepatitis monthly
0
kavous firouznia advanced diagnostic and interventional radiology research center (adir), tehran university of medical sciences, tehran, ir iran
hossein ghanaati advanced diagnostic and interventional radiology research center (adir), tehran university of medical sciences, tehran, ir iran; advanced diagnostic and interventional radiology research center (adir), tehran university of medical sciences, tehran, ir iran. tel: +98- 912 6825703
seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, ir iran
payam azadeh department of radiation oncology, shahid beheshti university of medical sciences, tehran, ir iran
mohsen nasiri toosi internal medicine department, imam-khomeini hospital, tehran university of medical sciences (tums), tehran, ir iran
arya haj mirzaian advanced diagnostic and interventional radiology research center (adir), tehran university of medical sciences, tehran, ir iran
conclusions we showed that in treatment of patients with unresectable hepatocellular carcinoma, tace significantly improved the disease and the overall survival rate. also, we introduce the tumor size, serum alp level, and number of liver involved segments as prognostic factors of the procedure. finally, tace can be recommended as the initial treatment for unresectable hcc patients. background ...
